Transaction in Own Shares
|
Bellevue Healthcare Trust plc |
|
|
|
|
|
Transaction in own shares |
|
|
|
|
|
Bellevue Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc. |
|
|
|
|
|
Date of purchase: |
19 December 2024 |
|
Number of ordinary shares purchased: |
1,701,353 |
|
Trading venue |
LSE |
|
Average price paid per share: |
135.14p |
|
|
|
|
The Company intends to hold the purchased shares in treasury. |
|
|
|
|
|
Following the above transaction, the Company holds 54,088,072 of its ordinary shares in treasury and has 261,064,237 ordinary shares in issue (excluding treasury shares). |
|
|
|
|
|
The Company's LEI is: 213800HQ3J3H9YF2UI82 |
|
|
|
|
|
Enquiries: |
|
|
Bellevue Asset Management (UK) Ltd. |
|
|
Mark Ghahramani |
|
|
Telephone: +44 (0) 203 326 2981 |
|
|
|
|
|
J.P. Morgan Cazenove |
|
|
James Bouverat (Sales) |
|
|
Telephone: +44 (0) 207 134 2224 |
|
|
|
|
|
NSM Funds (UK) Limited |
|
|
Brian Smith, Ciara McKillop |
|
|
Telephone: +44 (0)20 3697 5770 |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Card Factory
- 1 hour ago HSBC Holdings
- 1 hour ago Direct Line Insurance Group
- 2 hours ago CRH (CDI)
- 3 hours ago Renalytix (Reg S)